Preview Citation


Jasem, J., Fisher, C. M., Amini, A., Shagisultanova, E., Rabinovitch, R., Borges, V. F., Elias, A., & Kabos, P. (2017). The 21-Gene Recurrence Score Assay for Node-Positive, Early-Stage Breast Cancer and Impact of RxPONDER Trial on Chemotherapy Decision-Making: Have Clinicians Already Decided?, Journal of the National Comprehensive Cancer Network J Natl Compr Canc Netw, 15(4), 494-503. Retrieved Dec 9, 2019, from